Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease
- PMID: 11734472
- DOI: 10.1164/ajrccm.164.supplement_2.2106067
Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease
Abstract
Airway epithelium represents the first line of defense against toxic inhalants. In some subjects, cigarette smoking causes airway inflammation, hypersecretion of mucus, and poorly reversible airflow limitation through mechanisms that are still largely unknown. Likewise, it is unclear why only some smokers develop chronic obstructive pulmonary disease (COPD). Two cell types consistently result in relation to chronic airflow limitation in COPD: neutrophils and CD8(+) cells. Neutrophils are compartmentalized in the mucosal surface of the airways and air spaces, that is, the epithelium and lumen, whereas CD8(+) cells exhibit a more extensive distribution along the subepithelial zone of the airways and lung parenchyma, including alveolar walls and arteries. This pattern of inflammatory cell distribution is observed in mild or moderate COPD, and in patients who have developed COPD, it is not modified by smoking cessation. The number of neutrophils further increases in the submucosa of patients with severe COPD, suggesting a role for these cells in the progression of the disease. Hypersecretion of mucus is a major manifestation in COPD. Mucus is produced by bronchial glands and goblet cells lining the airway epithelium. Unlike mucous gland enlargement, greater mucosal inflammation is associated with sputum production. Whereas neutrophil infiltration of submucosal glands occurs only in smokers with COPD, goblet cell hyperplasia in peripheral airways occurs both in smokers with or without COPD, suggesting that the major determinant of goblet cell hyperplasia is cigarette smoke itself.
Similar articles
-
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation.Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):1016-21. doi: 10.1164/ajrccm.161.3.9907080. Am J Respir Crit Care Med. 2000. PMID: 10712357
-
Remodeling in asthma and chronic obstructive lung disease.Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S28-38. doi: 10.1164/ajrccm.164.supplement_2.2106061. Am J Respir Crit Care Med. 2001. PMID: 11734464 Review.
-
Airway inflammation in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S17-20. doi: 10.1164/ajrccm.160.supplement_1.6. Am J Respir Crit Care Med. 1999. PMID: 10556163 Review.
-
Pharmacological blockade of the DP2 receptor inhibits cigarette smoke-induced inflammation, mucus cell metaplasia, and epithelial hyperplasia in the mouse lung.J Pharmacol Exp Ther. 2010 Mar;332(3):764-75. doi: 10.1124/jpet.109.161919. Epub 2009 Dec 8. J Pharmacol Exp Ther. 2010. PMID: 19996299
-
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):822-6. doi: 10.1164/ajrccm.157.3.9709027. Am J Respir Crit Care Med. 1998. PMID: 9517597
Cited by
-
Red blood cells stimulate human lung fibroblasts to secrete interleukin-8.Inflammation. 2003 Apr;27(2):71-8. doi: 10.1023/a:1023274532456. Inflammation. 2003. PMID: 12797546
-
Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.Br J Pharmacol. 2009 Jul;157(6):892-906. doi: 10.1111/j.1476-5381.2009.00170.x. Epub 2009 Jun 5. Br J Pharmacol. 2009. PMID: 19508401 Free PMC article. Review.
-
Chronic rhinosinusitis and risk of lung cancer in the Singapore Chinese Health Study.Int J Cancer. 2008 Sep 15;123(6):1398-402. doi: 10.1002/ijc.23623. Int J Cancer. 2008. PMID: 18548585 Free PMC article.
-
Increased human Ca²⁺-activated Cl⁻ channel 1 expression and mucus overproduction in airway epithelia of smokers and chronic obstructive pulmonary disease patients.Respir Res. 2012 Jun 25;13(1):55. doi: 10.1186/1465-9921-13-55. Respir Res. 2012. PMID: 22731784 Free PMC article.
-
Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients.Lung. 2015 Jun;193(3):335-43. doi: 10.1007/s00408-015-9717-7. Epub 2015 Mar 21. Lung. 2015. PMID: 25794567
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials